Abstract:The term small extracellular vesicle (sEV) is a comprehensive term that includes any type of cell-derived, membrane-delimited particle that has a diameter < 200 nm, and which includes exosomes and smaller microvesicles. sEVs transfer bioactive molecules between cells and are crucial for cellular homeostasis and particularly during tumor development, where sEVs provide important contributions to the formation of the premetastic niche and to their altered metabolism. sEVs are thus legitimate targets for intervention and have also gained increasing interest as an easily accessible source of biomarkers because they can be rapidly isolated from serum/plasma and their molecular cargo provides information on their cell-of origin. To target sEVs that are specific for a given cell/disease it is essential to identify EV surface proteins that are characteristic of that cell/disease. Mass-spectrometry based proteomics is widely used for the identification and quantification of sEV proteins. The methods used for isolating the sEVs, preparing the sEV sample for proteomics analysis, and mass spectrometry analysis, can have a strong influence on the results and requires careful consideration. This review provides an overview of the approaches used for sEV proteomics and discusses the inherent compromises regarding EV purity versus depth of coverage. Additionally, it discusses the practical applications of the methods to unravel the involvement of sEVs in regulating the metabolism of pancreatic ductal adenocarcinoma (PDAC). The metabolic reprogramming in PDAC includes enhanced glycolysis, elevated glutamine metabolism, alterations in lipid metabolism, mitochondrial dysfunction and hypoxia, all of which are crucial in promoting tumor cell growth. A thorough understanding of these metabolic adaptations is imperative for the development of targeted therapies to exploit PDAC's vulnerabilities.

The Diagnostic and Prognostic Value of Plasmatic Exosome Count in Cancer Patients and in Patients with Other Pathologies

The Importance of Detecting, Quantifying, and Characterizing Exosomes as a New Diagnostic/Prognostic Approach for Tumor Patients

Extracellular Vesicles and Their Potential Use in Monitoring Cancer Progression and Therapy: The Contribution of Proteomics

Extracellular vesicles proteins for early cancer diagnosis: From omics to biomarkers

Diagnostic potential of exosomal extracellular vesicles in oncology

Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools

Exosomes and Extracellular Vesicles as Emerging Theranostic Platforms in Cancer Research

Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology

The Role of Exosomes in Breast Cancer Diagnosis

Extracellular vesicles in immunomodulation and tumor progression

The Rise of Extracellular Vesicles as New Age Biomarkers in Cancer Diagnosis: Promises and Pitfalls

Pancreatic Cancer Small Extracellular Vesicles (Exosomes): A Tale of Short- and Long-Distance Communication

Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring

Extracellular vesicles in cancer: challenges and opportunities for clinical laboratories

Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology

Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy

Exosomes: from basic research to clinical diagnostic and therapeutic applications in cancer

Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology

Exosome-based strategies for Diagnosis and Therapy

Extracellular vesicles in pancreatic cancer: a new era in precision medicine